Legis Daily

To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.

USA115th CongressHR-1245| House 
| Updated: 3/3/2017
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (29)
Marcy Kaptur (Democratic)John Garamendi (Democratic)Barbara Lee (Democratic)Mark Pocan (Democratic)James R. Langevin (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Michelle Lujan Grisham (Democratic)Ro Khanna (Democratic)Keith Ellison (Democratic)Raja Krishnamoorthi (Democratic)Pramila Jayapal (Democratic)Peter J. Visclosky (Democratic)Eleanor Holmes Norton (Democratic)Brad Sherman (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Louise McIntosh Slaughter (Democratic)Janice D. Schakowsky (Democratic)Beto O'Rourke (Democratic)Jared Polis (Democratic)Peter Welch (Democratic)Earl Blumenauer (Democratic)Robert A. Brady (Democratic)Gwen Moore (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Affordable and Safe Prescription Drug Importation Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. The FDA, within two years, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 28, 2017

Latest Companion Bill Action

S 115-469
Introduced in Senate
Feb 28, 2017
Introduced in House
Feb 28, 2017
Referred to the House Committee on Energy and Commerce.
Mar 3, 2017
Referred to the Subcommittee on Health.
  • February 28, 2017

    Latest Companion Bill Action

    S 115-469
    Introduced in Senate


  • February 28, 2017
    Introduced in House


  • February 28, 2017
    Referred to the House Committee on Energy and Commerce.


  • March 3, 2017
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 115-1776: To improve access to affordable prescription drugs.
  • S 115-469: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
  • S 115-3411: A bill to ensure medications are affordable.
  • S 115-771: A bill to improve access to affordable prescription drugs.
Administrative law and regulatory proceduresCanadaCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsPrescription drugsTrade restrictionsUser charges and fees

To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.

USA115th CongressHR-1245| House 
| Updated: 3/3/2017
Affordable and Safe Prescription Drug Importation Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. The FDA, within two years, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 28, 2017

Latest Companion Bill Action

S 115-469
Introduced in Senate
Feb 28, 2017
Introduced in House
Feb 28, 2017
Referred to the House Committee on Energy and Commerce.
Mar 3, 2017
Referred to the Subcommittee on Health.
  • February 28, 2017

    Latest Companion Bill Action

    S 115-469
    Introduced in Senate


  • February 28, 2017
    Introduced in House


  • February 28, 2017
    Referred to the House Committee on Energy and Commerce.


  • March 3, 2017
    Referred to the Subcommittee on Health.
Elijah E. Cummings

Elijah E. Cummings

Democratic Representative

Maryland

Cosponsors (29)
Marcy Kaptur (Democratic)John Garamendi (Democratic)Barbara Lee (Democratic)Mark Pocan (Democratic)James R. Langevin (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Rosa L. DeLauro (Democratic)Michelle Lujan Grisham (Democratic)Ro Khanna (Democratic)Keith Ellison (Democratic)Raja Krishnamoorthi (Democratic)Pramila Jayapal (Democratic)Peter J. Visclosky (Democratic)Eleanor Holmes Norton (Democratic)Brad Sherman (Democratic)Tulsi Gabbard (Democratic)Jamie Raskin (Democratic)Louise McIntosh Slaughter (Democratic)Janice D. Schakowsky (Democratic)Beto O'Rourke (Democratic)Jared Polis (Democratic)Peter Welch (Democratic)Earl Blumenauer (Democratic)Robert A. Brady (Democratic)Gwen Moore (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-1776: To improve access to affordable prescription drugs.
  • S 115-469: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
  • S 115-3411: A bill to ensure medications are affordable.
  • S 115-771: A bill to improve access to affordable prescription drugs.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCanadaCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsPrescription drugsTrade restrictionsUser charges and fees